tiprankstipranks
Trending News
More News >

iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details

Story Highlights
  • iX Biopharma’s S$2,000,000 convertible bonds will mature on July 24, 2025.
  • The conversion price for the bonds is set at S$0.12 per share, with potential adjustments in takeover scenarios.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details

Don’t Miss TipRanks’ Half-Year Sale

iX Biopharma Ltd. ( (SG:42C) ) has shared an update.

iX Biopharma Ltd. has announced the maturity date for its S$2,000,000 convertible bonds, which will mature on July 24, 2025. The conversion period will end on June 23, 2025, and the bonds can be converted into new ordinary shares at a conversion price of S$0.12 per share. In the event of a takeover offer, the conversion price may be adjusted but will not fall below S$0.07. This announcement provides clarity on the financial instruments available to stakeholders and may impact the company’s financial strategy and shareholder value.

More about iX Biopharma Ltd.

iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, with a market focus on healthcare solutions.

Average Trading Volume: 241,313

Technical Sentiment Signal: Sell

Current Market Cap: S$15.1M

For a thorough assessment of 42C stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1